Trial Profile
A Phase 2a, Proof of Concept Trial, Testing Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2019
Price :
$35
*
At a glance
- Drugs Delgocitinib (Primary)
- Indications Eczema
- Focus Proof of concept; Therapeutic Use
- Sponsors LEO Pharma
- 29 Aug 2019 Results assessing efficacy and safety of topical delgocitnib in patients with hand eczema published in the British Journal of Dermatology
- 26 Oct 2016 Status changed from active, no longer recruiting to completed.
- 26 Apr 2016 Status changed from recruiting to active, no longer recruiting.